Workflow
限制性股票激励计划
icon
Search documents
德林海: 申港证券股份有限公司关于无锡德林海环保科技股份有限公司2025年限制性股票激励计划首次授予相关事项之独立财务顾问报告
Zheng Quan Zhi Xing· 2025-08-29 17:02
Core Viewpoint - The report outlines the approval and implementation of the 2025 Restricted Stock Incentive Plan for Wuxi Delinhai Environmental Technology Co., Ltd, detailing the necessary procedures and conditions for granting restricted stocks to eligible participants [3][4][14]. Group 1: Approval Process - The incentive plan was approved during the board meeting on July 18, 2025, with subsequent meetings confirming the details and the list of eligible participants [3][4]. - The plan underwent a public disclosure period from July 19 to July 28, 2025, with no objections raised against the proposed participants [4]. - The first extraordinary shareholders' meeting on August 6, 2025, approved the plan and authorized the board to handle related matters [4][5]. Group 2: Granting Details - The first grant date is set for August 28, 2025, with a total of 2.732059 million shares granted, representing 2.42% of the company's total share capital of 113 million shares [6]. - The grant price is established at 11.42 RMB per share, with shares sourced from either repurchased shares or newly issued shares to the participants [6]. - The plan's validity extends up to 48 months, with shares vesting in three phases based on specific timelines and conditions [6][10]. Group 3: Vesting Conditions - The vesting schedule includes 40% of shares vesting after 12 months, 30% after 24 months, and the remaining 30% after 36 months from the grant date [10][12]. - Shares cannot be transferred or used as collateral before they vest, and any additional shares from capital increases will also be subject to the same vesting conditions [12]. Group 4: Impact on Financials - The independent financial advisor recommends that the company account for the costs associated with the incentive plan in accordance with relevant accounting standards, noting potential dilution effects on shareholders [14].
凌钢股份: 北京市竞天公诚律师事务所关于凌源钢铁股份有限公司2025年第三次临时股东会的法律意见书
Zheng Quan Zhi Xing· 2025-08-29 17:02
Group 1 - The company held its third extraordinary shareholders' meeting on August 28, 2025, to discuss two key proposals [3][5][7] - The proposals included the repurchase and cancellation of part of the restricted stock from the 2024 incentive plan and changes to the registered capital along with amendments to the company's articles of association [3][6] - The meeting was convened following the board's resolution on August 12, 2025, and the notice was published on August 13, 2025, detailing the meeting's time, location, and voting procedures [2][3] Group 2 - A total of 1 shareholder attended the meeting in person, representing 1,067,395,366 shares, which is 37.9025% of the total voting shares [3][5] - Additionally, 284 shareholders participated via online voting, representing 922,808,888 shares, or 32.7683% of the total voting shares [3][5] - The voting process was conducted both in-person and through the Shanghai Stock Exchange's online voting system, with specific time slots allocated for the online voting [5][6] Group 3 - The first proposal regarding the repurchase and cancellation of restricted stocks received 1,989,843,132 votes in favor, accounting for the majority of the votes cast [6] - The second proposal concerning changes to registered capital and amendments to the articles of association was approved with 1,989,911,122 votes in favor [6][7] - The voting results were verified and confirmed to be in compliance with Chinese laws and the company's articles of association [7]
美迪西: 北京安理(上海)律师事务所关于上海美迪西生物医药股份有限公司2025年限制性股票激励计划的法律意见书
Zheng Quan Zhi Xing· 2025-08-29 17:01
Core Viewpoint - The legal opinion letter confirms the compliance and legality of Shanghai Medicilon Inc.'s 2025 Restricted Stock Incentive Plan, indicating that the company is qualified to implement this plan and has followed necessary legal procedures [2][20][24]. Group 1: Company Overview - Shanghai Medicilon Inc. is a legally established and validly existing joint-stock company listed on the Shanghai Stock Exchange, with its stock code being 688202 [5][6]. - The company specializes in the research and development of drugs for AIDS, cancer sensitizers, genetic engineering vaccines, and biopharmaceutical intermediates [5]. Group 2: Incentive Plan Details - The 2025 Restricted Stock Incentive Plan involves granting a total of 1 million shares, representing 0.74% of the company's total share capital of 13,435.2184 million shares [7][9]. - The plan includes an initial grant of 800,000 shares (0.60% of total share capital) and a reserved portion of 200,000 shares (0.15% of total share capital) [9][10]. Group 3: Eligibility and Compliance - The incentive plan targets 385 core employees, accounting for 16.39% of the total workforce of 2,349 employees as of December 31, 2024 [7][8]. - The plan's eligibility criteria ensure that no inappropriate candidates are included, adhering to regulations set by the China Securities Regulatory Commission [8][24]. Group 4: Granting and Vesting Conditions - The grant price for the restricted stock is set at 31.37 yuan per share, which is compliant with the higher of the average trading price prior to the plan's announcement [14][15]. - The vesting schedule stipulates that shares will vest in two phases, with the first 50% vesting after 12 months and the remaining 50% after 24 months, contingent on performance targets being met [12][18]. Group 5: Legal Procedures and Disclosure - The company has completed necessary legal procedures, including board and supervisory committee approvals, and is set to disclose relevant documents within two trading days [20][22]. - The company has committed not to provide financial assistance to incentive plan participants, ensuring compliance with regulatory requirements [24].
燕麦科技: 关于作废部分已授予尚未归属的2022年限制性股票的公告
Zheng Quan Zhi Xing· 2025-08-29 17:01
Core Viewpoint - Shenzhen Oat Technology Co., Ltd. has announced the cancellation of part of the unvested restricted stock from the 2022 incentive plan due to the departure of certain incentive targets, resulting in a total of 206,800 shares being invalidated [1][4][5]. Group 1: Decision Process and Disclosure - The board of directors approved the proposal to cancel part of the unvested restricted stock at the second meeting of the fourth board on August 28, 2025 [1]. - The independent directors provided opinions on whether the 2022 restricted stock incentive plan would benefit the company's sustainable development and whether it would harm the interests of the company and all shareholders [1][2]. - The supervisory board verified the relevant matters of the incentive plan and issued related verification opinions [1][2]. Group 2: Specifics of the Canceled Restricted Stock - The cancellation was based on the regulations of the "Management Measures for Equity Incentives of Listed Companies" and the company's incentive plan, as 12 incentive targets had left the company, disqualifying them from the incentive program [4][5]. - The number of incentive targets for the 2022 plan was adjusted from 45 to 33, with 196,000 shares being canceled [4][5]. Group 3: Impact on the Company - The cancellation of the restricted stock will not have a significant impact on the company's operational situation, nor will it affect the stability of the technical and management teams [5]. - The board's remuneration and assessment committee believes that the cancellation aligns with relevant laws and regulations and does not harm the interests of the company and its shareholders [5][6]. Group 4: Legal Opinions - Guangdong Xinda Law Firm concluded that the adjustments and cancellations related to the 2022 incentive plan have received the necessary approvals and authorizations, and the conditions for vesting have been met [6][7].
美迪西: 美迪西:2025年限制性股票激励计划实施考核管理办法
Zheng Quan Zhi Xing· 2025-08-29 17:01
Core Points - The company has established a 2025 Restricted Stock Incentive Plan to enhance corporate governance and attract talent while aligning the interests of shareholders, the company, and core teams [1][2] - The plan aims to ensure the achievement of long-term development strategies and operational goals while safeguarding shareholder interests [1][2] Assessment Objectives - The purpose of the assessment is to strengthen the execution of the incentive plan, quantify specific goals, and promote a scientific, standardized, and institutionalized management of the assessment process [2] - The assessment will objectively and fairly evaluate employee performance and contributions, providing a comprehensive basis for the execution of the incentive plan [2] Assessment Principles - The assessment will adhere to principles of fairness, justice, and transparency, strictly evaluating the incentive objects according to the established guidelines [2] - Assessment indicators will be aligned with the company's medium to long-term development strategy and annual operational goals, as well as the performance, capability, and attitude of the incentive objects [2] Assessment Scope - The assessment applies to all incentive objects defined in the plan, including core employees but excluding independent directors and supervisors [2] - All incentive objects must have signed labor or employment contracts with the company or its subsidiaries during the assessment period [2] Assessment Institutions and Execution - The company's Compensation and Assessment Committee will lead and review the assessment of incentive objects [2] - The Human Resources and Finance Departments will form an assessment team responsible for collecting and providing relevant data, ensuring its authenticity and reliability [2] Performance Assessment Indicators and Standards - The vesting of restricted stocks will depend on both company-level and individual-level assessment results [3] - Company-level performance assessment targets for the fiscal years 2025 and 2026 include specific revenue growth thresholds, with the first vesting period requiring a minimum of 10% revenue growth and the second period requiring 20% [3][4] Assessment Period and Frequency - The assessment period for the restricted stock incentive plan spans the fiscal years 2025 and 2026, with annual assessments conducted for both company-level and individual-level performance [5] Assessment Procedures - The Human Resources and Finance Departments will conduct the assessments under the guidance of the Compensation Committee, maintaining records of the results and submitting a performance assessment report [5] Assessment Results Management - Assessment results will be communicated to the assessed individuals within five working days after the assessment, with provisions for appeals to the Compensation Committee [5] - Records of the assessment results will be archived as confidential documents [5] Additional Provisions - The Compensation Committee is responsible for formulating and revising the assessment guidelines, which will be implemented upon approval by the shareholders' meeting [6]
芯源微: 北京市邦盛律师事务所关于芯源微2023年限制性股票激励计划授予价格调整、首次授予部分第二个归属期归属条件成就暨部分限制性股票作废事项之法律意见书
Zheng Quan Zhi Xing· 2025-08-29 17:01
法律意见书 北京市邦盛律师事务所 关于 沈阳芯源微电子设备股份有限公司 部分第二个归属期归属条件成就暨部分限制性股票 作废事项 之 法 律 意 见 书 [2025]邦盛股字第 080 号 中国·北京·海淀区中关村大街19号新中关大厦A座12层 电话(Tel):(010)82870288 传真(Fax):(010)82870299 二○二五年八月 北京市邦盛律师事务所 法律意见书 北京市邦盛律师事务所 关于沈阳芯源微电子设备股份有限公司 个归属期归属条件成就暨部分限制性股票作废事项之 [2025]邦盛股字第 080 号 致:沈阳芯源微电子设备股份有限公司 北京市邦盛律师事务所(以下简称"本所")接受沈阳芯源微电子设备股份 有限公司(以下简称"公司")委托,作为公司 2023 年限制性股票激励计划(以 下简称"本次激励计划")的专项法律顾问,根据《中华人民共和国公司法》(以 下简称"《公司法》")、《中华人民共和国证券法》(以下简称"《证券法》")、 《上市公司股权激励管理办法》(以下简称"《管理办法》")、《上海证券交 易所科创板股票上市规则》《科创板上市公司自律监管指南第 4 号——股权激励 信息披露》等有关 ...
龙旗科技: 关于变更注册资本、修订《公司章程》并办理工商变更登记的的公告
Zheng Quan Zhi Xing· 2025-08-29 16:52
证券代码:603341 证券简称:龙旗科技 公告编号:2025-090 上海龙旗科技股份有限公司 关于变更注册资本、修订《公司章程》 鉴于上述总股本、注册资本的变更,根据《中华人民共和国公司法》《中华 人民共和国证券法》《上市公司章程指引》和《上海证券交易所股票上市规则》 等有关规定,公司对《公司章程》部分条款进行了修订。具体修订内容拟定如下: 一、关于变更注册资本的基本情况 公司于 2025 年 5 月 26 日召开了第四届董事会第七次会议、第四届监事会第 六次会议,会议审议通过了《关于向公司 2025 年限制性股票激励计划激励对象 首次授予限制性股票的议案》,同意向 269 名激励对象授予 433.5 万股限制性股 票。在缴款验资环节及后续办理登记的过程中,4 名激励对象因个人原因自愿放 弃认购获授的限制性股票合计 5 万股。因此,本次激励计划首次授予部分的限制 性股票实际授予激励对象人数由 269 人变更为 265 人,首次授予部分的限制性股 票登记数量由 433.5 万股变更为 428.5 万股。 票在中国证券登记结算有限责任公司上海分公司完成登记手续,授予登记的限制 性股票数量为 428.5 万股。 ...
爱柯迪: 上海市通力律师事务所关于爱柯迪股份有限公司回购注销部分限制性股票相关事项的法律意见书
Zheng Quan Zhi Xing· 2025-08-29 16:52
Core Viewpoint - The legal opinion letter from Shanghai Tongli Law Firm confirms that Aikodi Co., Ltd. has obtained the necessary approvals for the repurchase and cancellation of certain restricted stocks as part of its sixth stock incentive plan, along with adjustments to the repurchase price [4][8]. Group 1: Approval and Authorization - Aikodi held the fourth board meeting on October 29, 2024, and the third extraordinary general meeting on November 19, 2024, where it approved the relevant proposals regarding the sixth stock incentive plan [8]. - The company has received necessary authorization to proceed with the repurchase and cancellation of restricted stocks for 30 individuals who left the company for personal reasons [7][8]. Group 2: Repurchase and Price Adjustment Details - The repurchase price for the restricted stocks has been adjusted to 6.85 yuan per share following the implementation of the 2024 profit distribution plan, which included a dividend of 1 yuan per share [7][9]. - The repurchase involves stocks that were granted but not yet released from restrictions due to the departure of the incentive recipients [9]. Group 3: Compliance and Legal Framework - The legal opinion is based on compliance with the Company Law, Securities Law, and relevant regulations from the China Securities Regulatory Commission and the Shanghai Stock Exchange [2][3]. - The repurchase and price adjustment must still comply with disclosure requirements and complete the necessary legal procedures for stock cancellation [10].
莱克电气: 莱克电气第六届董事会薪酬与考核委员会关于公司2020年限制性股票激励计划首次授予部分第五个限售期解除限售条件成就的核查意见
Zheng Quan Zhi Xing· 2025-08-29 16:52
Core Viewpoint - The Compensation and Assessment Committee of Lek Electric Co., Ltd. has verified that the conditions for the release of the fifth lock-up period of the 2020 Restricted Stock Incentive Plan have been met, allowing for the release of 2,256,030 shares for 236 eligible participants [1] Summary by Relevant Sections - **Verification of Conditions**: The committee confirms that the conditions for the fifth lock-up period of the 2020 Restricted Stock Incentive Plan have been achieved, in accordance with relevant laws and regulations [1] - **Eligible Participants and Shares**: A total of 236 eligible participants are confirmed, with a total of 2,256,030 shares eligible for release from lock-up [1] - **Compliance with Regulations**: The release of the restricted stock complies with the "Management Measures for Equity Incentives of Listed Companies" and does not harm the interests of the company or its shareholders [1]
莱克电气: 上海市锦天城律师事务所关于公司2020年限制性股票激励计划首次授予部分第五个限售期解除限售条件成就、回购注销部分激励对象已获授但尚未解锁的限制性股票及调整回购价格的法律意见书
Zheng Quan Zhi Xing· 2025-08-29 16:52
Core Viewpoint - The legal opinion letter from Shanghai Jintiancheng Law Firm confirms that Leike Electric Co., Ltd. has fulfilled the necessary legal procedures for the release of restrictions on its 2020 restricted stock incentive plan, the repurchase and cancellation of unvested shares, and the adjustment of repurchase prices [1][15]. Group 1: Approval and Authorization - The company obtained legal authorization from the board of directors for the release of restrictions, repurchase, and price adjustment related to the 2020 restricted stock incentive plan [6][10]. - The board of directors approved the relevant proposals during the meetings held on July 23, 2020, and August 28, 2025 [6][10]. Group 2: Release of Restrictions - The fifth release period for the restricted stock will end on September 17, 2025, allowing for a 20% release of the shares [7]. - The conditions for the release of restrictions have been met, including no adverse audit opinions and no disqualifications of the incentive targets [8][9]. Group 3: Repurchase and Price Adjustment - The company will repurchase a total of 86,450 shares due to the departure of four incentive targets and the failure of 23 targets to meet performance criteria [10][12]. - The adjusted repurchase price for the restricted shares is set at 8.94 yuan per share, which includes interest [12][14]. - The total amount for the repurchase will be approximately 784,024.17 yuan, funded by the company's own resources [12][14]. Group 4: Impact on Share Structure - Following the repurchase, the number of restricted shares will decrease from 2,342,480 to 2,256,030, while the total number of shares will be adjusted accordingly [13].